NECTAR LIFESCIENCES Financial Statement Analysis
|
||
|
The Revenues of NECTAR LIFESCIENCES have decreased by -8.70% YoY .
The Earnings Per Share (EPS) of NECTAR LIFESCIENCES has decreased by Negative YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
NECTAR LIFESCIENCES Last 5 Annual Financial Results
[BOM: 532649|NSE : NECLIFE]
| Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹1,524 Cr | ₹1,669 Cr | ₹1,543 Cr | ₹2,366 Cr | ₹2,783 Cr |
| Expenses | ₹1,471 Cr | ₹1,510 Cr | ₹1,442 Cr | ₹2,147 Cr | ₹2,519 Cr |
| Operating Profit (Excl OI) | ₹53 Cr | ₹159 Cr | ₹101 Cr | ₹220 Cr | ₹264 Cr |
| Other Income | ₹43 Cr | ₹11 Cr | ₹11 Cr | ₹4.36 Cr | ₹6.04 Cr |
| Interest | ₹79 Cr | ₹79 Cr | ₹112 Cr | ₹126 Cr | ₹148 Cr |
| Depreciation | ₹59 Cr | ₹57 Cr | ₹60 Cr | ₹61 Cr | ₹63 Cr |
| Profit Before Tax | ₹-42 Cr | ₹34 Cr | ₹-85 Cr | ₹37 Cr | ₹59 Cr |
| Profit After Tax | ₹-24 Cr | ₹25 Cr | ₹-73 Cr | ₹32 Cr | ₹48 Cr |
| Consolidated Net Profit | ₹-24 Cr | ₹25 Cr | ₹-73 Cr | ₹32 Cr | ₹48 Cr |
| Earnings Per Share (Rs) | ₹-1.08 | ₹1.12 | ₹-3.27 | ₹1.44 | ₹2.12 |
| PAT Margin (%) | -1.38 | 1.30 | -4.15 | 1.20 | 1.53 |
| ROE(%) | -2.25 | 2.33 | -6.67 | 2.84 | 4.40 |
| ROCE(%) | 1.97 | 5.77 | 1.41 | 8.32 | 10.29 |
| Total Debt/Equity(x) | 0.71 | 0.79 | 0.85 | 0.69 | 0.82 |
Key Financials |
||
| Market Cap | : | ₹ 785.9 Cr |
| Revenue (TTM) | : | ₹ 1,633.1 Cr |
| Net Profit(TTM) | : | ₹ 8.1 Cr |
| EPS (TTM) | : | ₹ 0.4 |
| P/E (TTM) | : | 97.3 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| NECTAR LIFESCIENCES | 2.6% | 16.4% | 94% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.1% | -6.3% | 53.5% |
| CIPLA | 1% | -5% | 53.3% |
| DR REDDYS LABORATORIES | 1.1% | 2.2% | 26% |
| ZYDUS LIFESCIENCES | 3.9% | -1.7% | 85.2% |
| DIVIS LABORATORIES | 3.2% | 15.3% | 23.6% |
| MANKIND PHARMA | -2.7% | 1.6% | NA |
| TORRENT PHARMACEUTICALS | -0.7% | 2.8% | 61.9% |
| LUPIN | 3.3% | 1.9% | 137.2% |
NECTAR LIFESCIENCES Revenues
[BOM: 532649|NSE : NECLIFE]
| Y-o-Y | -8.70 % |
| 5 Yr CAGR | -13.98 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹1,524 Cr | -8.70 | |
| Mar2022 | ₹1,669 Cr | 8.13 | |
| Mar2021 | ₹1,543 Cr | -34.78 | |
| Mar2020 | ₹2,366 Cr | -14.97 | |
| Mar2019 | ₹2,783 Cr | - | |
NECTAR LIFESCIENCES Operating Profit
[BOM: 532649|NSE : NECLIFE]
| Y-o-Y | -66.57 % |
| 5 Yr CAGR | -33.07 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹53 Cr | -66.57 | |
| Mar2022 | ₹159 Cr | 56.27 | |
| Mar2021 | ₹101 Cr | -53.82 | |
| Mar2020 | ₹220 Cr | -16.83 | |
| Mar2019 | ₹264 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -63.37 % |
| 5 Yr CAGR | -22.18 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 3.48% | -63.37 | |
| Mar2022 | 9.5% | 44.60 | |
| Mar2021 | 6.57% | -29.20 | |
| Mar2020 | 9.28% | -2.21 | |
| Mar2019 | 9.49% | - | |
NECTAR LIFESCIENCES Profit After Tax
[BOM: 532649|NSE : NECLIFE]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹-24 Cr | Negative | |
| Mar2022 | ₹25 Cr | Positive | |
| Mar2021 | ₹-73 Cr | Negative | |
| Mar2020 | ₹32 Cr | -32.11 | |
| Mar2019 | ₹48 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | -1.38 % | Negative | |
| Mar2022 | 1.3 % | Positive | |
| Mar2021 | -4.15 % | Negative | |
| Mar2020 | 1.2 % | -21.57 | |
| Mar2019 | 1.53 % | - | |
NECTAR LIFESCIENCES Earnings Per Share (EPS)
[BOM: 532649|NSE : NECLIFE]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹-1.08 | Negative | |
| Mar2022 | ₹1.12 | Positive | |
| Mar2021 | ₹-3.27 | Negative | |
| Mar2020 | ₹1.44 | -32.08 | |
| Mar2019 | ₹2.12 | - | |
NECTAR LIFESCIENCES Return on Capital Employed (ROCE)
[BOM: 532649|NSE : NECLIFE]
| Y-o-Y | -65.86 % |
| 5 Yr CAGR | -33.85 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 1.97% | -65.86 | |
| Mar2022 | 5.77% | 309.22 | |
| Mar2021 | 1.41% | -83.05 | |
| Mar2020 | 8.32% | -19.14 | |
| Mar2019 | 10.29% | - | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Current Share Price | : | ₹35.0 |
| Current MarketCap | : | ₹ 785.9 Cr |
| Updated EOD on | : | May 02,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | 2.6% |
16.4% |
94% |
| SENSEX | 1% |
2.2% |
23.7% |
NECTAR LIFESCIENCES related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about NECTAR LIFESCIENCES Financials
How the annual revenues of NECTAR LIFESCIENCES have changed ?
The Revenues of NECTAR LIFESCIENCES have decreased by -8.70% YoY .
How the Earnings per Share (EPS) of NECTAR LIFESCIENCES have changed?
The Earnings Per Share (EPS) of NECTAR LIFESCIENCES has decreased by Negative YoY .
Check out Intrinsic Value of Peers of NECTAR LIFESCIENCES
Compare Stock Analytics of Peers of NECTAR LIFESCIENCES
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
